Koziolek, M.; Augustijns, P.; Berger, C.; Cristofoletti, R.; Dahlgren, D.; Keemink, J.; Matsson, P.; McCartney, F.; Metzger, M.; Mezler, M.;
et al. Challenges in Permeability Assessment for Oral Drug Product Development. Pharmaceutics 2023, 15, 2397.
https://doi.org/10.3390/pharmaceutics15102397
AMA Style
Koziolek M, Augustijns P, Berger C, Cristofoletti R, Dahlgren D, Keemink J, Matsson P, McCartney F, Metzger M, Mezler M,
et al. Challenges in Permeability Assessment for Oral Drug Product Development. Pharmaceutics. 2023; 15(10):2397.
https://doi.org/10.3390/pharmaceutics15102397
Chicago/Turabian Style
Koziolek, Mirko, Patrick Augustijns, Constantin Berger, Rodrigo Cristofoletti, David Dahlgren, Janneke Keemink, Pär Matsson, Fiona McCartney, Marco Metzger, Mario Mezler,
and et al. 2023. "Challenges in Permeability Assessment for Oral Drug Product Development" Pharmaceutics 15, no. 10: 2397.
https://doi.org/10.3390/pharmaceutics15102397
APA Style
Koziolek, M., Augustijns, P., Berger, C., Cristofoletti, R., Dahlgren, D., Keemink, J., Matsson, P., McCartney, F., Metzger, M., Mezler, M., Niessen, J., Polli, J. E., Vertzoni, M., Weitschies, W., & Dressman, J.
(2023). Challenges in Permeability Assessment for Oral Drug Product Development. Pharmaceutics, 15(10), 2397.
https://doi.org/10.3390/pharmaceutics15102397
